Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235928

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235928

Continuous Renal Replacement Therapy Market Forecasts to 2028 - Global Analysis By Product, Modality, Age Group, End User and Geography

PUBLISHED:
PAGES: 175+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $1.31 billion in 2022 and is expected to reach $2.23 billion by 2028 growing at a CAGR of 9.3% during the forecast period. A common form of treatment for critically ill patients with acute kidney injury (AKI), particularly those with unstable hemodynamics, is continuous renal replacement therapy (CRRT). It includes the process of removing solutes from blood via hemofiltration, hemodialysis, or a combination of the two.

According to the American Hospital Association, there were 208 federal government hospitals, 625 nonfederal psychiatric hospitals, and 5,141 community hospitals in the country in 2021. The demand for CRRT systems is also rising due to the significant rise in AKI hospital admissions and the growing geriatric population, which is fueling market expansion.

Market Dynamics:

Driver:

Increase in acute kidney injury and chronic kidney diseases

The main risk factors for acute kidney injury are diabetes, hypertension, and an ageing population. Diabetes prevalence is rising quickly across the globe. As a result, the number of patients with acute kidney injury is growing along with the prevalence of diabetes. Growing awareness among medical professionals could lessen its occurrence and enhance the management of underlying diseases in the elderly population.

Restraint:

High procedural cost

People in emerging economies value affordability, so they favour lower-cost goods. Despite the high cost in developing nations, a large portion of the population cannot afford these measures because of their low purchasing power. This restricts both the developed and developing world's demand for and adoption of this therapy.

Opportunity:

Implementation of new technologies

Technology advancements in equipment design have greatly benefited the use of therapy in critically ill patients. These innovations have significantly broadened the scope of extracorporeal therapies in the ICU. Additionally, software integration is likely to emerge as a brand-new tool for cutting-edge machinery.

Threat:

Stringent healthcare regulations

Companies are vulnerable to a changing regulatory environment because they are subject to a number of existing laws and regulations, and non-compliance will likely have a negative impact on their operations, financial condition, and business. The fact that businesses' operations and goods are subject to a variety of government regulations as healthcare industry participants is a hindrance to the market's expansion.

COVID-19 Impact:

The overall impact of COVID-19 remains positive on the market. The pandemic has significantly increased the demand for renal replacement fluids on a global scale. When compared to historical US populations, the demand for RRT among COVID-19 patients has increased five times. China and Italy, for example, reported AKI rates as high as 29%, according to a study by the International Society of Nephrology 2020. Early implementation of continuous renal replacement therapy (CRRT) is crucial for reducing the incidence of AKI, which is on the rise as a result of COVID-19 infection.

The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to be the largest during the forecast period

The continuous venovenous hemodiafiltration (CVVHDF) segment is estimated to have a lucrative growth, due to the increase in dialysis procedures. This treatment modality results in comprehensive removal and replacement of solutes and fluids within the blood. It also includes principles of diffusion and convection, hence propelling the growth of the market.

The Adults segment is expected to have the highest CAGR during the forecast period

The adults segment is anticipated to witness the fastest CAGR growth during the forecast period, due to various regulatory approvals for adult and rise in development of novel products. Additionally, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising technological advancement, surging healthcare expenditure. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of products. Additionally, surge in focus of leading manufacturers on expanding their geographical presence is the factor driving the region growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rise in geriatric population and increasing incidences of acute kidney injury. High adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Key players in the market

Some of the key players in Continuous Renal Replacement Therapy (CRRT) market include: Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Infomed SA, Medica SpA, Medical Components, Inc., Medites Pharma Spol. S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd, NIPRO Corporation, NxStage Medical, Inc. and Toray Medical Co., Ltd.

Key Developments:

In February 2021, DaVita accomplished its first position by including a secure telehealth platform, DaVita Care Connect, into its home dialysis program. It is one of the various connective technologies in its suite of services designed to improve outcomes and the care experience for patients deciding to treat at home.

In December 2020, Medtronic plc announced the launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. This technique is indicated to be used in acute kidney injury or fluid overloaded patients that need hemodialysis. It is planned to supply continuous renal replacement therapy (CRRT) to patients weighing between 2.5 & 10 kg.

In April 2020, Fresenius Medical Care, a worldwide provider of dialysis products and services, has announced the release of an advisory that calls for clinical care principles for patients with advanced chronic kidney during the pandemic crisis. The advisory states that patients who need renal replacement therapy during the COVID-19 crisis should still be offered the treatment decided in consultation with their physicians.

Products Covered:

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • CRRT Systems
  • Other Products

Modalities Covered:

  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Age Groups Covered:

  • Adults
  • Pediatrics /Neonates

End Users Covered:

  • Hospitals
  • Ambulatory Centers
  • Specially Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Product Code: SMRC22525

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Continuous Renal Replacement Therapy (CRRT) Market, By Product

  • 5.1 Introduction
  • 5.2 Dialysates and Replacement Fluids
  • 5.3 Disposables
  • 5.4 Hemofilters
  • 5.5 Bloodline Sets & Tubes
  • 5.6 CRRT Systems
  • 5.7 Other Products

6 Global Continuous Renal Replacement Therapy (CRRT) Market, By Modality

  • 6.1 Introduction
  • 6.2 Slow Continuous Ultra-Filtration (SCUF)
  • 6.3 Continuous Venovenous Hemofiltration (CVVH)
  • 6.4 Continuous Venovenous Hemodialysis (CVVHD)
  • 6.5 Continuous Venovenous Hemodiafiltration (CVVHDF)

7 Global Continuous Renal Replacement Therapy (CRRT) Market, By Age Group

  • 7.1 Introduction
  • 7.2 Adults
  • 7.3 Pediatrics /Neonates

8 Global Continuous Renal Replacement Therapy (CRRT) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Centers
  • 8.4 Specially Clinics
  • 8.5 Other End Users

9 Global Continuous Renal Replacement Therapy (CRRT) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Asahi Kasei Corporation
  • 11.2 B. Braun Medical Inc.
  • 11.3 Baxter International Inc.
  • 11.4 Chongqing Shanwaishan Science and Technology Co., Ltd.
  • 11.5 Fresenius Medical Care AG & Co. KGaA
  • 11.6 Infomed SA
  • 11.7 Medica SpA
  • 11.8 Medical Components, Inc.
  • 11.9 Medites Pharma Spol. S.R.O.
  • 11.10 Medtronic PLC
  • 11.11 Nikkiso Co., Ltd.
  • 11.12 Ningbo Tianyi Medical Appliance Co., Ltd
  • 11.13 NIPRO Corporation
  • 11.14 NxStage Medical, Inc.
  • 11.15 Toray Medical Co., Ltd.
Product Code: SMRC22525

List of Tables

  • Table 1 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 4 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 5 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 6 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 7 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 8 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 9 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 10 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 11 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 12 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 13 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 14 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 15 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 16 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 17 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 18 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 19 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 20 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 21 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 22 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 23 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 24 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 25 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 26 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 27 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 28 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 29 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 30 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 31 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 32 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 33 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 34 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 35 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 36 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 37 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 38 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 39 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 40 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 41 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 42 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 43 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 44 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 45 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 46 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 47 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 48 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 49 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 50 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 51 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 52 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 53 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 54 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 55 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 56 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 57 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 58 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 59 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 60 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 61 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 62 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 63 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 64 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 65 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 66 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 67 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 68 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 69 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 70 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 71 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 72 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 73 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 74 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 75 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 76 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 77 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 78 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 79 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 80 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 81 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 82 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 83 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 84 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 85 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 86 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 87 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 88 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 89 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 90 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 91 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 92 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 93 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 94 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 95 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 96 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 97 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 98 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 99 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 100 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 101 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 102 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 103 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 104 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 105 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 106 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 107 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 108 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 109 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 110 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 111 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 112 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 113 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 114 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 115 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 116 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 117 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 118 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 119 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 120 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 121 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 122 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 123 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 124 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 125 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 126 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!